LPL and hypertriglyceridemia: The reduction of low-density-lipoprotein cholesterol (LDL-C), mediated through the upregulation of lipo-protein-lipase (LPL), significantly decreases hypertriglyceridemia and the incidence of CVD (Hooper et al., 2020; Lockyer et al., 2022).